Latest Insider Transactions at Vaxxinity, Inc. (VAXX)
This section provides a real-time view of insider transactions for Vaxxinity, Inc. (VAXX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vaxxinity, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vaxxinity, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,872
-0.29%
|
$22,872
$1.67 P/Share
|
|
Sep 08
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,089
-0.29%
|
$25,089
$1.67 P/Share
|
|
Sep 07
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,516
-0.23%
|
$18,516
$1.79 P/Share
|
|
Sep 07
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,312
-0.23%
|
$20,312
$1.79 P/Share
|
|
Sep 06
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,839
-0.06%
|
$4,839
$1.88 P/Share
|
|
Sep 06
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,308
-0.06%
|
$5,308
$1.88 P/Share
|
|
Apr 26
2023
|
Peter Diamandis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
475,537
+19.09%
|
$0
$0.89 P/Share
|
|
Jan 23
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
405,217
-4.42%
|
$1,215,651
$3.35 P/Share
|
|
Jan 23
2023
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
95,475
-4.42%
|
$286,425
$3.35 P/Share
|
|
Dec 02
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,121
-0.12%
|
$22,242
$2.57 P/Share
|
|
Dec 02
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,620
-0.12%
|
$5,240
$2.57 P/Share
|
|
Dec 01
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
270,964
-2.87%
|
$541,928
$2.97 P/Share
|
|
Dec 01
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,843
-2.87%
|
$127,686
$2.97 P/Share
|
|
Sep 06
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,243
-0.27%
|
$50,486
$2.4 P/Share
|
|
Sep 06
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,115
-0.27%
|
$24,230
$2.4 P/Share
|
|
Aug 25
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,757
-0.24%
|
$45,514
$2.33 P/Share
|
|
Aug 25
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,923
-0.24%
|
$21,846
$2.33 P/Share
|
|
Aug 24
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
83,786
-0.87%
|
$167,572
$2.39 P/Share
|
|
Aug 24
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,214
-0.87%
|
$80,428
$2.39 P/Share
|
|
Aug 23
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,785
-0.35%
|
$67,570
$2.45 P/Share
|
|
Aug 23
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,215
-0.35%
|
$32,430
$2.45 P/Share
|
|
Aug 22
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,640
+3.7%
|
$0
$0.57 P/Share
|
|
Aug 15
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
26,005
+28.26%
|
$0
$0.57 P/Share
|
|
Jul 29
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+33.33%
|
$0
$0.57 P/Share
|
|
Jun 16
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 16
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 16
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 13
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
92,569
-0.95%
|
$185,138
$2.43 P/Share
|
|
Jun 13
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,431
-0.95%
|
$88,862
$2.43 P/Share
|
|
Jun 10
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
28,378
-0.29%
|
$56,756
$2.8 P/Share
|
|
Jun 10
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,622
-0.29%
|
$27,244
$2.8 P/Share
|
|
Jun 09
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 09
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 09
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 08
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
Jun 08
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
Jun 08
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
May 03
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.57 P/Share
|
|
Apr 27
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 27
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 27
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 26
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 26
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 26
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 25
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,038
+0.15%
|
$24,114
$3.37 P/Share
|
|
Apr 25
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
8,038
+0.02%
|
$24,114
$3.37 P/Share
|
|
Apr 25
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
8,038
+0.02%
|
$24,114
$3.37 P/Share
|
|
Jan 24
2022
|
Peter Diamandis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
652,764
+47.22%
|
$2,611,056
$4.12 P/Share
|
|
Jan 13
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.57 P/Share
|
|
Dec 31
2021
|
James Chui Director |
BUY
Open market or private purchase
|
Direct |
6,000
+30.0%
|
$30,000
$5.48 P/Share
|